Clinical Trials Directory

Trials / Terminated

TerminatedNCT02511483

Genetic Predictors of Analgesic Efficacy of Propranolol for Treating Postoperative Pain

Contribution of COMT Haplotypes in Propranolol Analgesic Efficacy for Treating Post-surgical Pain After Laparoscopic Hemicolectomy

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is a randomized, double-blind, placebo controlled clinical trial. The main purpose of this study is to determine if postsurgical pain ratings are improved with treatment with oral Propranolol, and if the effectiveness of treatment can be modified by the presence or absence of SNPs (Single Nucleotide Polymorphism) associated with Cathecol-O-MethylTransferase (COMT) and mu-opioid receptor (MOR1) activity. The treatment period will last for three days and the observation period will last for six months. Effectiveness of treatment will be assessed by means of morphine consumption through quantitative evaluation of IV-PCA (Patient Controlled Analgesia) morphine as primary outcome measure.

Conditions

Interventions

TypeNameDescription
DRUGPropranolol PO20 mg PO BID Day of Surgery, 30 mg PO BID Day I and Day II post-op.
DRUGIV-PCA morphineMorphine delivered via IV-PCA pump for 48 hours after surgery with standard program: bolus 1 mg, lock out 7 minutes, no background infusion.
DRUGPlacebo POPlacebo tablets administered with the same schedule of Propranolol tablets
PROCEDUREQuantitative Sensory Testing (QST)Assessment of PPT (Pressure Pain Threshold) by pressure algometer and assessment of the post-op area of hyperalgesia by von Frey hair no. 16.
OTHERPsychometric assessmentQuestionnaires assessing for sleep quality (PSQI: Pittsburgh Sleep Quality Index), pain quality (sfMGPQ-Short Form-McGill Pain Questionnaire), somatization-depression-anxiety (SCL-90-R: Symptom Checklist 90 Revised), evolution of post-operative chronic pain (PQRS: Post-operative Quality of Recovery Scale)
GENETICCOMT-haplotypesAssessing of High Pain Sensitivity (HPS), Average Pain Sensitivity (APS) and Low Pain Sensitivity (LPS) haplotypes for COMT by genotyping peripheral blood samples.

Timeline

Start date
2015-05-18
Primary completion
2016-11-12
Completion
2016-11-12
First posted
2015-07-30
Last updated
2021-09-28

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02511483. Inclusion in this directory is not an endorsement.